Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

61.20 +0.81 (+1.34%)
Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Globus Medical (GMED) Q1 2024 Earnings Call Transcript
GMED earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q1 2024
GMED stock results show that Globus Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Globus Medical Reports First Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
For those who appreciate growth without the sticker shock, GLOBUS MEDICAL INC - A (NYSE:GMED) is worth considering. 
Via Chartmill
Globus Medical Schedules First Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Looking for growth without the hefty price tag? Consider NYSE:GMED.
Via Chartmill
The Latest Analyst Ratings For Globus Medical
 
Via Benzinga
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
With automated machines set to integrate into everyday functionalities, these are the robotics stocks that could make you rich. 
Via InvestorPlace
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.
For those who appreciate growth without the sticker shock, GLOBUS MEDICAL INC - A (NYSE:GMED) is worth considering. 
Via Chartmill
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
Exploring GLOBUS MEDICAL INC - A's Technical Signals and Breakout Potential.
With a solid technical rating of 7 out of 10, GLOBUS MEDICAL INC - A (NYSE:GMED) is showing strong indications of a possible breakout. 
Via Chartmill
NYSE:GMED is not too expensive for the growth it is showing.
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
Key Takeaways From Globus Medical Analyst Ratings
 
Via Benzinga
Globus Medical: Q4 Earnings Insights
 
Via Benzinga
Why NYSE:GMED Is a Standout High-Growth Stock in a Consolidation Phase.
GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
 
Via Benzinga
Globus Medical (GMED) Q4 2023 Earnings Call Transcript
GMED earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
While growth is established for GLOBUS MEDICAL INC - A (NYSE:GMED), the stock's valuation remains reasonable. 
Via Chartmill
NYSE:GMED qualifies as a high growth stock and is consolidating.
GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
In the world of growth stocks, NYSE:GMED shines as a value proposition. 
Via Chartmill
Assessing Globus Medical: Insights From 5 Financial Analysts
 
Via Benzinga
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth 
From Globus Medical
Via GlobeNewswire
Do Investors Have Too Much Money Out of the Market?
We've also got a look at two stocks worth watching: Globus Medical and RPM International. 
Via The Motley Fool
NYSE:GMED stands out as a growth opportunity that won't break the bank.
Despite its growth, GLOBUS MEDICAL INC - A (NYSE:GMED) remains within the realm of affordability. 
Via Chartmill
7 Healthcare Stocks Taking Medicine to the Next Level
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider. 
Via InvestorPlace
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
From Globus Medical
Via GlobeNewswire
3 Stocks at the Forefront of Medical Robotics
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid. 
Via InvestorPlace
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.